Tefibazumab

Tefibazumab is a humanized IgG1κ monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A. Tefibazumab can be used for the research of serious Staphylococcus aureus infections[1][2].

Product Specifications

CAS Number

[521079-87-8]

Product Name Alternative

INH-H 2002

UNSPSC

12352203

Target

Others

Type

Inhibitory Antibodies

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/tefibazumab.html

Purity

99.90

Solubility

H2O

Smiles

[Tefibazumab]

Molecular Weight

(147.04 kDa)

References & Citations

[1]pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug;50 (8) :2751-5. |[2]Reilley S, et, al. Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers. Antimicrob Agents Chemother. 2005 Mar;49 (3) :959-62.